Preview
December 2019
In the next issue of Pharma Technology Focus, we chart the development of flu vaccines, investigate the dangers of treating children using drugs that have not been studied or approved for paediatric patients, debate whether countries should look to repatriate active pharmaceutical ingredient manufacturing following contamination scandals in China and India.
Also, we profile the current state of pharma manufacturing in Ireland, examine the validity of research that links an imbalance in the gut microbiome to recurrent miscarriage, and take a look at the role of PR in the pharmaceutical industry,
Plus, we find out how Gavi, a Vaccine Alliance plans to support the immunisation of 300 million children against 18 diseases, and examine the problems with cancer trial design and administration.
EDITORIAL
Editor | Eloise McLennan
Group Editor | Susanne Hauner
Commissioning Editor | Daniel Garrun
Writers | Allie Nawrat, Abi Millar, Chris Lo
Magazine Designer | Marzia Del Gaone
Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Petra Konyi-Kiss, Maria Gimenez, Martina Labaiova
Lead Designer | John Hammond
Digital Publishing Director | Duncan West
Advertising
Sales Manager | Nimai Amin
+44 (0) 207 936 6453
Marketing
For media partnership enquiries please contact our publishing assistant: Sophie Hoare
Pharma Technology focus is powered by h5mag
read past issues of pharma technology focus HERE
Pharma Technology Focus is a product of Net Resources International. Copyright 2019 Net Resources International, a trading division of Kable Intelligence Limited. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.